openPR Logo
Press release

Non-Invasive Cancer Diagnostics Market - Global Industry Trends & Forecast to 2028

Non-Invasive Cancer Diagnostics Market - Global Industry

Cancer is one of the top causes of death globally, with a higher incidence in developed and developing markets. The rapid technological advancements in diagnostic tests are anticipated to accelerate industry growth as healthcare professionals focus on developing effective screening and treatment solutions to check prevalence levels. Numerous healthcare agencies and market players are launching different programs promoting different advanced diagnostics, thus accelerating market growth.

Full Access Report:

https://www.databridgemarketresearch.com/reports/global-noninvasive-cancer-diagnostics-market

Top Trending Reports:

https://1234submission1234.blogspot.com/2023/10/cladding-market-global-industry-trends.html

https://1234submission1234.blogspot.com/2023/10/eco-friendly-straws-market-size-share.html

https://1234submission1234.blogspot.com/2023/10/egg-yolk-replacer-market-usd-393.html

Non-invasive cancer diagnostics is a procedure to identify varied cancer problems with minimal body incision, such as cancer. The procedure usually consists of numerous techniques, such as identifying genetic structure, biomarker, molecular biology change, and imaging technologies. This process does not harm the body as it is non-invasive and allows no point or cut
Several hospitals in underdeveloped and developing nations cannot invest in diagnostic imaging equipment due to high costs and budgetary constraints. However, due to the growing demand for diagnostic imaging in these countries, hospitals that cannot afford to purchase new and advanced imaging systems opt for rebuilt ones. Thus, this factor restraints the market growth.

Key players operating in the non-invasive cancer diagnostics market include:

Abbott (U.S.)
Thermo Fisher Scientific, Inc. (U.S.)
Illumina, Inc. (U.S.)
QIAGEN (Germany)
F. Hoffmann-La Roche Ltd (Switzerland)
Agilent Technologies, Inc. (U.S.)
Quest Diagnostics Incorporated. (U.S.)
Merck KGaA, (Germany)

Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-Invasive Cancer Diagnostics Market - Global Industry Trends & Forecast to 2028 here

News-ID: 3255433 • Views:

More Releases from Data Bridge Market Research

Europe Epigenetics Diagnostic Market Size Projected to Hit USD 5.43 billion by 2032, Expanding at a 12.70% CAGR
Europe Epigenetics Diagnostic Market Size Projected to Hit USD 5.43 billion by 2 …
Market Summary As per Data Bridge Market Research analysis, the Europe Epigenetics Diagnostic Market was estimated at USD 2.34 billion in 2025. The market is expected to grow from USD 2.08 billion in 2024 to USD 5.43 billion by 2032, at a CAGR of 12.70% during the forecast period driven by the rising demand for early-stage precision oncology, expanding utilization of non-invasive liquid biopsy platforms, increasing research investments in histone modification
Age-Related Macular Degeneration (AMD) Anti-VEGF Therapeutics Market: Industry Analysis and Forecast to 2032 | CAGR 6.80%
Age-Related Macular Degeneration (AMD) Anti-VEGF Therapeutics Market: Industry A …
Market Summary As per Data Bridge Market Research analysis, the Age-Related Macular Degeneration (AMD) Disease - Anti-VEF Market was estimated at USD 15.59 billion in 2025. The market is expected to grow from USD 16.65 billion in 2026 to USD 24.71 billion in 2032, at a CAGR of 6.80% during the forecast period with driven by the rising demand for effective retinal disease therapies, increasing prevalence of age-related vision disorders, advancements
Yogurt Powder Market Size Expected to Reach USD 1.41 Billion by 2032 at a CAGR of 8.10%
Yogurt Powder Market Size Expected to Reach USD 1.41 Billion by 2032 at a CAGR o …
Market Summary As per Data Bridge Market Research analysis, the Yogurt Powder Market was estimated at USD 0.28 billion in 2025. The market is expected to grow from USD 0.30 billion in 2026 to USD 1.41 billion in 2032, at a CAGR of 8.10% during the forecast period with driven by the rising demand for shelf-stable dairy ingredients, growing consumption of functional and protein-enriched foods, expansion of the food processing industry,
Pressure Transmitter Market Size, Share & Industry Trends Analysis Report - Global Industry Outlook, Growth, and Forecast to 2032 | CAGR of 3.86% with Market Expected to Reach USD 4.44 Billion by 2032
Pressure Transmitter Market Size, Share & Industry Trends Analysis Report - Glob …
As per Data Bridge Market Research analysis, the Pressure Transmitter Market was estimated at USD 3.41 billion in 2025. The market is expected to grow from USD 3.54 billion in 2026 to USD 4.44 billion in 2032, at a CAGR of 3.86% during the forecast period (2026-2032), driven by the rising demand for industrial automation, increasing adoption of Industry 4.0 technologies, expansion of oil & gas and process industries, and

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For